Sanochemia: successful signing of contract with VIVID IMAGING Technologies Ltd.

Sanochemia Pharmazeutika AG, Vienna, listed on the stock exchange (ISIN AT0000776307, ISIN DE000A1G7JQ9), announces the conclusion of a contract with VIVID IMAGING Technologies Ltd. for the distribution of Medical Devices.VIVID IMAGING, a Hong Kong based company with subsidiaries in the US, Europe and partnerships globally, is specialized in the development, production and distribution of medical devices. The portfolio includes contrast injectors, disposables (such as injector syringes and tubing lines) as well as imaging devices. 

With the signing of this contract, both companies benefit from synergies in distribution and market access. SANOCHEMIA is now also able to provide high quality next generation contrast injectors as well as consumables along with its pharmaceutical products. SANOCHEMIA expects a maximum sales growth with the launch of this new product line.

“With access to VIVID IMAGING’s next generation injector series, SANOCHEMIA is able to strengthen its competences in the medical field. This partnership enables us to offer our international customers a wide range of daily use products in the field of imaging diagnostic.” Dr. Klaus Gerdes, CMO, COO.

Mark Chelberg, President of VIVID IMAGING also welcomes the cooperation with SANOCHEMIA: “We look forward to our partnership with SANOCHEMIA. Our value range contrast injectors and accessory syringe line complement SANOCHEMIA’s core product line, enabling SANOCHEMIA to offer its client’s a turnkey contrast and delivery solution.”

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)